Welcome to IHUB and NWBO board! DCVax-Prosate never started the Phase III trial due to funding issues and management has had discussions in partnering this trial. It was withdrawn due to their cost and focus on international Phase III GBM trial and now DCVax-Direct.
The prior progression free survival and overall survival results in the Phase II were statistically better than Dendreon Provenge and any other similar trial. You can get this information from NWBO web site.
Short and sweet version so I hope this explains it for you.
News 
Market Data 
Discover 
